Please wait a minute...

ISSN 1006-298X CN 32-1425/R

Home
About Journal
Editorial Board
Contribution
Journal
- Accepted
- Current Issue
- Archive
- Most Download
- Most Read
- Most Cited
- E-mail Alert
- RSS
Subscription
Advertising
Contact Us
中文

Journal

Current Issue Accepted Archive Adv Search Most Read Most Download Most Cited E-mail Alert RSS

WeChat

Current Issue

2021, 30 (3)

Previous Issue Next Issue

Anti-CD38 monoclonal antibody: new choice for patients with relapsed/refractory systemic light chain amyloidosis HUANG Xianghua, LIU Zhihong 2021, 30 (3): 201-202. DOI: 10.3969/j.issn.1006298X.2021.03.001 Abstract( 509 ) PDF (398KB) ( 477 )

Hypoxia-inducible factor prolyl hydroxylase inhibitors for renal anemia:new approach and new challenges HAO Chuanming, LI Jing 2021, 30 (3): 203-204. DOI: 10.3969/j.issn.1006298X.2021.03.002 Abstract( 307 ) PDF (235KB) ( 319 )

Efficacy and safety of daratumumab in treatment of relapsed／refractory systemic light chain amyloidosis REN Guisheng, GUO Jinzhou, ZHAO Liang, XU Weiwei, CHEN Wencui, LIU Zhihong, HUANG Xianghua 2021, 30 (3): 205-210. DOI: 10.3969/j.issn.1006298X.2021.03.003 Abstract( 1430 ) PDF (1313KB) ( 389 )

Efficacy of Roxadustat for erythropoietin hyporesponsive anemia in hemodialysis patients DONG Jianhua, FAN Wenjing, WU Bian, HUANG Li, LI Chuan, FAN Rong, GE Yongchun 2021, 30 (3): 211-216. DOI: 10.3969/j.issn.1006298X.2021.03.004 Abstract( 769 ) PDF (612KB) ( 650 )

Roxadustat for anemia in maintenance hemodialysis patients treated with large dose recombinant human erythropoietin SUN Lingshuang, XUE Jinhong, WEI Meng, SHI Kehui, LIU Hua, XU Chao, JIANG Hongli 2021, 30 (3): 217-221. DOI: 10.3969/j.issn.1006298X.2021.03.005 Abstract( 998 ) PDF (957KB) ( 439 )

Efficacy and safety of Roxadustat for renal anemia in patients undergoing peritoneal dialysis CHENG Shuiqin, ZHOU Tingting, ZHANG Zhihong, LOU Lixuan, CHEN Yunmin, WANG Fang, LYU Guilan, WANG Jinquan, YU Yusheng 2021, 30 (3): 222-227. DOI: 10.3969/j.issn.1006298X.2021.03.006 Abstract( 622 ) PDF (610KB) ( 384 )

Clinical characteristics and prognosis of acute aortic dissection with kidney injury WANG Yang, LI Zhe, SUN Zhiyuan, XU Shutian, ZHANG Lei, LI Shijun 2021, 30 (3): 228-233. DOI: 10.3969/j.issn.1006298X.2021.03.007 Abstract( 419 ) PDF (843KB) ( 354 )

A single center study on effect of LifePort continuous hypothermic perfusion on preservation of marginal donor kidney of donation after cardiac death SUN Dong, JIANG Xin, ZHAO He, WANG Yizhe, QYU Qingshan 2021, 30 (3): 234-238. DOI: 10.3969/j.issn.1006298X.2021.03.008 Abstract( 290 ) PDF (1693KB) ( 250 )

Experimental study of receptor interaction protein kinase 1 inhibitor (necrostatin-1) in treatment of lupus nephritis ZHU Yan, PENG Lin, ZHANG Mingchao, WANG Lizhi, XU Xiaodong, ZENG Caihong, QIN Weisong, LIU Zhihong 2021, 30 (3): 239-245. DOI: 10.3969/j.issn.1006298X.2021.03.009 Abstract( 321 ) PDF (3539KB) ( 360 )

Biological therapies in the treatment of lupus nephritis CHEN Wei, XIA Xi 2021, 30 (3): 246-247. DOI: 0.3969/j.issn.1006298X.2021.03.010 Abstract( 167 ) PDF (448KB) ( 313 )

The application experience of rituximab in lupus nephritis LI Xiao 2021, 30 (3): 248-249. DOI: 10.3969/j.issn.1006298X.2021.03.011 Abstract( 293 ) PDF (421KB) ( 420 )

Biologic agents in the treatment of lupus nephritis HU Zhangxue 2021, 30 (3): 250-251. DOI: 10.3969/j.issn.1006298X.2021.03.012 Abstract( 197 ) PDF (430KB) ( 326 )

Anti-CD38 monoclonal antibody-based therapy for systemic light chain amyloidosis HUANG Xianghua, LIU Zhihong 2021, 30 (3): 252-257. DOI: 10.3969/j.issn.1006298X.2021.03.013 Abstract( 440 ) PDF (1301KB) ( 431 )

Pathophysiology and progress of treatment in heatstroke XU Shutian, LI Shijun 2021, 30 (3): 258-262. DOI: 10.3969/j.issn.1006298X.2021.03.014 Abstract( 562 ) PDF (912KB) ( 789 )

Mechanism of cholesterol crystals induced inflammation and renal injury LI XiyueWU Dan, ZENG Caihong 2021, 30 (3): 263-267. DOI: 10.3969/j.issn.1006298X.2021.03.015 Abstract( 1407 ) PDF (791KB) ( 423 )

Progress in application of mTORC1 inhibitors in focal segmental glomerulosclerosis WANG Sisi, GUAN Na 2021, 30 (3): 273-278. DOI: 10.3969/j.issn.1006298X.2021.03.017 Abstract( 261 ) PDF (960KB) ( 331 )

Timing of renal replacement therapy for acute kidney injury CHENG Huixin, YU Xiangyou 2021, 30 (3): 279-283. DOI: 10.3969/j.issn.1006298X.2021.03.018 Abstract( 350 ) PDF (573KB) ( 374 )

Application of extracorporeal cell intervention therapy in clinic DAI Xinlin, GONG Dehua 2021, 30 (3): 284-288. DOI: 10.3969/j.issn.1006298X.2021.03.019 Abstract( 322 ) PDF (778KB) ( 354 )

Research progress of critical illness polyneuromyopathy in renal transplant recipients YANG Jingbo, BAI Shengliang, LIU Yihe 2021, 30 (3): 289-293. DOI: 10.3969/j.issn.1006298X.2021.03.020 Abstract( 247 ) PDF (772KB) ( 371 )

Daratumumab in a patient with relapsed light chain amyloidosis GUO Jinzhou, REN Guisheng, LIANG Dandan, HUANG Xianghua 2021, 30 (3): 294-298. DOI: 10.3969/j.issn.1006298X.2021.03.021 Abstract( 1301 ) PDF (1742KB) ( 440 )